Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer

2023237 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT02394795.

Good health and well-being

Published in: JAMA

Volume 329, Issue 15, pp. 1271-1271

Field-Weighted Citation Impact: 54.25